Yumi Kanbayashi

18PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsAllergyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Oct 28, 2025
Three Cases of Advanced Melanoma With Severe irAE Colitis With Rapid Tumor Progression Following Infliximab Administration.

Emi Yamazaki, Taku Fujimura, Yumi Kambayashi

|Mar 25, 2025
Two cases of advanced melanoma with BRAF L597 mutation: Options for systemic treatment.

Ryo Amagai, Taku Fujimura, Yumi Kambayashi

|Jan 25, 2025
Impact of Hyaluronic Acid on the Cutaneous T-Cell Lymphoma Microenvironment: A Novel Anti-Tumor Mechanism of Bexarotene.

Tetsuya Ikawa, Emi Yamazaki, Ryo Amagai

|Jun 04, 2024
A phase II multicentre study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-programmed cell death 1 antibody-refractory malignant melanoma: TM5614-MM trial.

Taku Fujimura, Koji Yoshino, Hiroshi Kato

|May 22, 2024
Analysis of surgical margins and prognostic factors in dermatofibrosarcoma protuberans after wide local excision: A multicenter study of 116 Japanese patients.

Yusuke Muto, Taku Fujimura, Akira Takahashi

|Apr 17, 2024
Radiation-induced cutaneous squamous cell carcinoma showing a significant response to pembrolizumab: A case report.

Manami Takahashi-Watanabe, Taku Fujimura, Ryo Amagai

Pageof 3

Frequent Collaborators

17 joint publications

Taku Fujimura

8 joint publications

Yoshihide Asano

7 joint publications

Emi Yamazaki

5 joint publications

Ryo Amagai